Biotech ETFs Suffer Seventh Week of Outflows

Investors continued to yank money out of biotechnology sector-related ETFs for the seventh consecutive week, the longest back-to-back weekly selling since late 2017. According to PiperJaffray analyst Christopher Raymond’s weekly note, investors withdrew money out of healthcare/biotech-specific...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.